News Releases

Sep 01, 2026

Keenova Marks the 2nd Annual National Hand Health Month with New Dupuytren's Contracture Mixed Reality Experience and Awareness Initiatives

Read More

Aug 20, 2026

Keenova Advances Podiatry Pipeline with First Patient Dosed in Phase 3 Trial of XIAFLEX® (collagenase clostridium histolyticum) for Hammer Toe

Read More

Aug 11, 2026

Keenova Reports Second Quarter 2026 Financial Results

Read More

Aug 03, 2026

Keenova Announces Publication of XIAFLEX® (collagenase clostridium histolyticum) Manuscript in Translational Andrology and Urology

Read More

Jul 30, 2026

Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026

Read More

Jul 13, 2026

Keenova Announces Publication of New Acthar® Gel (repository corticotropin injection) Manuscript in the Journal of Comparative Effectiveness Research

Read More

Jul 08, 2026

Keenova Announces Positive Phase 3 Results in Clinical Trial of XIAFLEX® (collagenase clostridium histolyticum) for Treating Plantar Fibromatosis

Read More

Jun 01, 2026

Keenova Champions Men's Health Month with Education and Outreach

Read More

May 15, 2026

Keenova Announces Newly Updated Peyronie's Disease Study Results at American Urology Association Meeting

Read More

May 12, 2026

Keenova Reports First Quarter 2026 Financial Results

Read More